why choose us

First received: May 04, 2023

Clinical Trial: Evaluating the SUBLOCADE Treatment Exit Strategy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Opioid Use Disorder

Study Type: OBSERVATIONAL


Official Title: A Phase IV Study to Evaluate the SUBLOCADE Treatment Exit Strategy

Brief Summary: The purpose of this study is to observe and assess the successful taper and opioid withdrawal experience after participants stop receiving SUBLOCADE because their healthcare provider determines their disease symptoms have been controlled for at least 9 months and they, together with their healthcare provider, plan to discontinue MOUD.

Read more